Stock Scorecard



Stock Summary for 908 Devices Inc (MASS) - $7.80 as of 11/7/2025 1:04:22 PM EST

Total Score

11 out of 30

Safety Score

24 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for MASS

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MASS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MASS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MASS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MASS (24 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 4
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for MASS

Sight Sciences, Inc. ( SGHT ) Reports Q3 Loss, Tops Revenue Estimates 11/6/2025 11:55:00 PM
Envoy Medical, Inc. ( COCH ) Expected to Beat Earnings Estimates: Should You Buy? 11/6/2025 3:00:00 PM
Penumbra ( PEN ) Q3 Earnings and Revenues Beat Estimates 11/5/2025 11:00:00 PM
InspireMD, Inc. ( NSPR ) Reports Q3 Loss, Tops Revenue Estimates 11/4/2025 1:15:00 PM
Will 908 Devices Inc. ( MASS ) Report Negative Earnings Next Week? What You Should Know 11/3/2025 3:00:00 PM
908 Devices ( MASS ) Surges 7.0%: Is This an Indication of Further Gains? 9/22/2025 12:57:00 PM
Cathie Wood Pounces On Peter Thiel-Backed Bullish Stock After Wild IPO Surge: Ark Buys Stock Worth $172.22 Million - ARK Fintech Innovation ETF ( BATS:ARKF ) , ARK Innovation ETF ( BATS:ARKK ) 8/14/2025 1:46:00 AM
908 Devices ( MASS ) Q2 Revenue Jumps 14% 8/6/2025 2:31:00 AM
908 Devices Inc. ( MASS ) Reports Q2 Loss, Tops Revenue Estimates 8/5/2025 12:20:00 PM
Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance 7/29/2025 11:30:00 AM

Financial Details for MASS

Company Overview

Ticker MASS
Company Name 908 Devices Inc
Country USA
Description 908 Devices Inc. is a pioneering technology firm that develops advanced measuring devices for chemical and biochemical analysis, focusing on cutting-edge solutions that enhance analytical capabilities across diverse industries. Headquartered in Boston, Massachusetts, the company harnesses its expertise in microfluidics and mass spectrometry to provide innovative instruments tailored for pharmaceuticals, biotechnology, and environmental monitoring. With a strong global footprint spanning North America, Europe, the Middle East, Africa, and Asia Pacific, 908 Devices is dedicated to meeting the increasing demand for efficient and reliable analytical tools, solidifying its position as a leader in the analytical instrument market.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 6/30/2025
Next Earnings Date 11/18/2025

Stock Price History

Last Day Price 7.80
Price 4 Years Ago 25.87
Last Day Price Updated 11/7/2025 1:04:22 PM EST
Last Day Volume 375,127
Average Daily Volume 332,880
52-Week High 9.34
52-Week Low 1.81
Last Price to 52 Week Low 330.94%

Valuation Measures

Trailing PE N/A
Industry PE 43.71
Sector PE 109.06
5-Year Average PE -13.27
Free Cash Flow Ratio 4.56
Industry Free Cash Flow Ratio 32.68
Sector Free Cash Flow Ratio 27.12
Current Ratio Most Recent Quarter 4.98
Total Cash Per Share 1.71
Book Value Per Share Most Recent Quarter 4.13
Price to Book Ratio 2.12
Industry Price to Book Ratio 4.11
Sector Price to Book Ratio 33.30
Price to Sales Ratio Twelve Trailing Months 4.27
Industry Price to Sales Ratio Twelve Trailing Months 4.58
Sector Price to Sales Ratio Twelve Trailing Months 15.71
Analyst Buy Ratings 4
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 36,085,700
Market Capitalization 281,468,460
Institutional Ownership 83.00%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -98.37%
Reported EPS 12 Trailing Months -2.36
Reported EPS Past Year -0.56
Reported EPS Prior Year -1.77
Net Income Twelve Trailing Months -18,444,000
Net Income Past Year -72,206,000
Net Income Prior Year -36,399,000
Quarterly Revenue Growth YOY 13.70%
5-Year Revenue Growth 27.11%
Operating Margin Twelve Trailing Months -64.20%

Balance Sheet

Total Cash Most Recent Quarter 61,751,000
Total Cash Past Year 44,032,000
Total Cash Prior Year 121,041,000
Net Cash Position Most Recent Quarter 46,751,000
Net Cash Position Past Year 29,032,000
Long Term Debt Past Year 15,000,000
Long Term Debt Prior Year 15,000,000
Total Debt Most Recent Quarter 15,000,000
Equity to Debt Ratio Past Year 0.88
Equity to Debt Ratio Most Recent Quarter 0.91
Total Stockholder Equity Past Year 114,592,000
Total Stockholder Equity Prior Year 165,491,000
Total Stockholder Equity Most Recent Quarter 148,817,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -29,280,000
Free Cash Flow Per Share Twelve Trailing Months -0.81
Free Cash Flow Past Year -30,849,000
Free Cash Flow Prior Year -27,104,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.06
MACD Signal 0.23
20-Day Bollinger Lower Band 5.19
20-Day Bollinger Middle Band 7.15
20-Day Bollinger Upper Band 9.10
Beta 0.45
RSI 48.06
50-Day SMA 5.07
150-Day SMA 6.15
200-Day SMA 8.74

System

Modified 11/6/2025 3:57:06 AM EST